Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | MPT0L145 |
Synonyms | |
Therapy Description |
MPT0L145 is a dual FGFR and PIK3C3 inhibitor, which enhances autophagy and may result in increased tumor cell death (PMID: 29222162, PMID: 31514441). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MPT0L145 | FGFR Inhibitor (Pan) 26 | MPT0L145 is a dual FGFR and PIK3C3 inhibitor, which enhances autophagy and may result in increased tumor cell death (PMID: 29222162, PMID: 31514441). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|